Vmn2r120 Inhibitors
Vmn2r120 inhibitors pertain to a niche category of chemical compounds with distinct molecular characteristics that allow them to selectively interact with the Vmn2r120 receptor, which is a specific subtype within the larger family of Vomeronasal type 2 receptors (V2Rs). These receptors are part of the chemosensory system and are typically implicated in the detection of pheromones, which are chemical substances that carry signals between individuals of the same species. The Vmn2r120 receptor operates as part of a complex sensory mechanism, where it binds to certain ligands, which are molecules that produce a signal by binding to a target protein, and thereby initiates a cascade of biochemical events inside the cell. Inhibitors of Vmn2r120 are designed to bind to this receptor and block its natural ligand from attaching, effectively shutting down the signaling pathway that would normally be activated upon ligand binding.
The chemical structure of Vmn2r120 inhibitors is often characterized by specific functional groups that enable them to have a high affinity for the Vmn2r120 receptor, and a conformation that closely matches the binding pocket of the receptor. This ensures that these inhibitors are effective in their role of preventing the natural ligand-receptor interaction. The development of such compounds involves detailed studies of the receptor's structure and the molecular dynamics that govern ligand binding. Researchers use an array of techniques, including computer-aided drug design, to predict how these inhibitors will interact with the receptor at the atomic level. Furthermore, the specificity of Vmn2r120 inhibitors is critical, as it determines their ability to bind to this particular receptor without affecting other V2R subtypes or unrelated proteins, which is a fundamental aspect of their design. The precision with which these inhibitors are crafted reflects a deep understanding of molecular recognition and the principles of biochemistry that govern the intricate dance of molecules within biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a potent and selective inhibitor of Raf kinase, which is upstream of the MAPK/ERK signaling pathway. Inhibition of Raf kinase by GW5074 would impede the activation of this pathway, potentially reducing the functional activity of Vmn2r120 if it is connected to MAPK/ERK signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). By inhibiting PI3K, LY294002 disrupts the PI3K/AKT pathway, which could indirectly affect Vmn2r120 function if Vmn2r120 is involved in cellular processes regulated by this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is a part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 can suppress the pathway, potentially affecting Vmn2r120 if it operates within this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. Inhibition of p38 MAP kinase by SB203580 can affect inflammatory response pathways that might be associated with the function of Vmn2r120, leading to its decreased activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated protein kinase (ROCK). By inhibiting ROCK, Y-27632 can alter cytoskeletal dynamics and cell motility, which could indirectly affect the function of Vmn2r120 if it is linked to these processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). By blocking JNK activity, SP600125 can modulate transcription factor pathways that may influence the function of Vmn2r120 if it has a role in JNK-mediated signaling events. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of src-family tyrosine kinases. By targeting these tyrosine kinases, PP2 can inhibit signaling pathways involved in cell growth and differentiation that may indirectly affect Vmn2r120 if it is part of these pathways. | ||||||
WZ 4002 | 1213269-23-8 | sc-364655 sc-364655A | 10 mg 50 mg | $180.00 $744.00 | 1 | |
WZ4002 is a selective inhibitor of the epidermal growth factor receptor (EGFR) kinase. As EGFR signaling is crucial for various cellular processes, inhibition by WZ4002 could affect Vmn2r120 activity if there is a link between Vmn2r120 function and EGFR-mediated signaling. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Dorsomorphin is an inhibitor of BMP signaling pathway via its action on the kinase activity of BMP type I receptors. This inhibition could affect Vmn2r120 if it is involved in the BMP signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of the mammalian target of rapamycin (mTOR) pathway, which is important for cell growth and proliferation. Inhibition of mTOR by Rapamycin could lead to a decrease in Vmn2r120 function if Vmn2r120 is associated with this pathway. | ||||||